Submit Your Feeds

Business News • MarketWire • Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program

Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program

Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program

Adenosine Antagonists Under Development for Use in Immuno-Oncology

View More : http://www.marketwired.com/mw/release.do?id=2085831&sourceType=3

Releted News by marketwire

SenseDriver Technologies Will Host Exclusive Viewings of Head Up Display Prototype at CES 2016

Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program